In situ Polymerization of a PEG Monomer from the C-Terminus of an Intein Fusion Protein Significantly Improves Pharmacokinetics and Tumor Accumulation

Weiping Gao,Ashutosh Chilkoti

2011-01-01

What problem does this paper attempt to address?

In Situ Growth Of A Peg-Like Polymer From The C Terminus Of An Intein Fusion Protein Improves Pharmacokinetics And Tumor Accumulation

Weiping Gao,Wenge Liu,Trine Christensen,Michael R Zalutsky,Ashutosh Chilkoti

DOI: https://doi.org/10.1073/pnas.1006044107

2010-01-01

Abstract:This paper reports a general in situ method to grow a polymer conjugate solely from the C terminus of a recombinant protein. GFP was fused at its C terminus with an intein; cleavage of the intein provided a unique thioester moiety at the C terminus of GFP that was used to install an atom transfer radical polymerization (ATRP) initiator. Subsequent in situ ATRP of oligo(ethylene glycol) methyl ether methacrylate (OEGMA) yielded a site-specific (C-terminal) and stoichiometric conjugate with high yield and good retention of protein activity. A GFP-C-poly(OEGMA) conjugate (hydrodynamic radius (R(h)): 21 nm) showed a 15-fold increase in its blood exposure compared to the protein (R(h): 3.0 nm) after intravenous administration to mice. This conjugate also showed a 50-fold increase in tumor accumulation, 24 h after intravenous administration to tumor-bearing mice, compared to the unmodified protein. This approach for in situ C-terminal polymer modification of a recombinant protein is applicable to a large subset of recombinant protein and peptide drugs and provides a general methodology for improvement of their pharmacological profiles.
A Novel Zwitterionic Copolymer with A Short Poly(Methyl Acrylic Acid) Block for Improving Both Conjugation and Separation Efficiency of A Protein Without Losing Its Bioactivity

Weifeng Lin,Hui Zhang,Jiang Wu,Zhen Wang,Haotian Sun,Jiang Yuan,Shengfu Chen

DOI: https://doi.org/10.1039/c3tb00474k

IF: 7.571

2013-01-01

Journal of Materials Chemistry B

Abstract:PEGylation of protein drugs has thus far been the most important method used in improving the stability and the circulation time, while lowering the immunogenicity of protein drugs. However, the loss of bioactivity of PEGylated protein drugs and the low recovery through the complicated separation process are the most challenging issues. To overcome these problems, a zwitterionic block copolymer poly(methyl acrylic acid-b-sulfobetaine methacrylate) (PMAA-b-PSBMA or abbreviated to PMS) has been chosen to modify a protein drug (uricase) since zwitterionic materials are superior to polyethylene glycol (PEG) in resistance to nonspecific protein adsorption, chemical stability and also low cytotoxicity. As indicated by the results, the conjugation between PMS and uricase could be achieved under 0.03 mg mL-1 of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) and 0.018 mg mL-1N-hydroxysuccinimide (NHS) through weak charge-induced adsorption of PMS on uricase, which is about 0.3% of the concentration for conventional protein-polymer conjugation. The conjugates, efficiently separated from the reaction solution and re-suspended in physiological solution through pH adjustment from pH 5.35 to 7.4, show about 133% of the original activity and better anti-trypsin digestion than the native uricase. These results demonstrate that the conjugation of a zwitterionic copolymer with a short poly(methyl acrylic acid) block could improve the stability of an enzyme without destructively affecting its bioactivity. This may open a new way for the delivery of therapeutic protein drugs.
A facile entrapment approach to construct PEGylated polyplexes for improving stability in physiological condition.

Youxiang Wang,Ping Chen,Jiacong Shen

DOI: https://doi.org/10.1016/j.colsurfb.2007.03.008

2007-01-01

Abstract:PEGylated polyplexes had been proved to improve the stability of DNA complexes. However, the conjugation reaction might reduce the capacity of efficient DNA complexation. Herein we described an easy and favorable approach to construct PEGylated polyplexes via entrapping poly(ethylene glycol) cholesterol ether (CPEG) into polyplexes. It was of interest to find the addition sequence of CPEG had great effect on the stability of polyplexes in physiological salt concentration. The addition of CPEG into the formed PEI25k/DNA polyplexes had no effect to improve the stability. Whereas by the “CPEG first” method of adding CPEG and PEI25k mixture into the DNA solution, the PEI25k/CPEG/DNA polyplexes showed excellent anti-aggregation effect and enhanced transfection efficiency in physiological condition. The difference performance might be explained by the possibility of CPEG entrapment. By the “CPEG first” method, PEGylated polyplexes was constructed due to the hydrophobic interaction between the cholesterol group of CPEG and hydrophobic charged-compensated core. The PEG coating significantly improved the stability of polyplexes in physiological condition. This facile entrapment approach to prepare PEGylated polyplexes might have great potential in non-viral gene delivery research and application.
In Situ Growth Of A Stoichiometric Peg-Like Conjugate At A Protein'S N-Terminus With Significantly Improved Pharmacokinetics

Weiping Gao,Wenge Liu,J. Andrew Mackay,Michael R. Zalutsky,Eric J. Toone,Ashutosh Chilkoti

DOI: https://doi.org/10.1073/pnas.0904378106

2009-01-01

Abstract:The challenge in the synthesis of protein-polymer conjugates for biological applications is to synthesize a stoichiometric (typically 1: 1) conjugate of the protein with a monodisperse polymer, with good retention of protein activity, significantly improved pharmacokinetics and increased bioavailability, and hence improved in vivo efficacy. Here we demonstrate, using myoglobin as an example, a general route to grow a PEG-like polymer, poly(oligo(ethylene glycol) methyl ether methacrylate) [poly(OEGMA)], with low polydispersity and high yield, solely from the N-terminus of the protein by in situ atom transfer radical polymerization (ATRP) under aqueous conditions, to yield a site-specific (N-terminal) and stoichiometric conjugate (1:1). Notably, the myoglobin-poly(OEGMA) conjugate [hydrodynamic radius (R-h): 13 nm] showed a 41-fold increase in its blood exposure compared to the protein (R-h: 1.7 nm) after IV administration to mice, thereby demonstrating that comb polymers that present short oligo(ethylene glycol) side chains are a class of PEG-like polymers that can significantly improve the pharmacological properties of proteins. We believe that this approach to the synthesis of N-terminal protein conjugates of poly(OEGMA) may be applicable to a large subset of protein and peptide drugs, and thereby provide a general methodology for improvement of their pharmacological profiles.
Site-specific in Situ Growth of an Interferon-Polymer Conjugate That Outperforms PEGASYS in Cancer Therapy.

Jin Hu,Guilin Wang,Wenguo Zhao,Weiping Gao

DOI: https://doi.org/10.1016/j.biomaterials.2016.04.035

IF: 14

2016-01-01

Biomaterials

Abstract:Conjugating therapeutic proteins and peptides to poly(ethylene glycol) (PEG) can improve their pharmacokinetics and therapeutic potential. However, PEGylation suffers from non-specific conjugation, low yield and immunogenicity. Herein we report a new and general methodology to synthesize a protein-polymer conjugate with site-specificity, high yield and activity, long circulation half-life and excellent therapeutic efficacy. A phospholipid polymer, poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC), was grown solely from the C-terminus of interferon-alpha to form a site-specific (C-terminal) and stoichiometric (1:1) PMPC conjugate of interferon-alpha in high yield. Notably, the PMPC conjugate showed 194- and 158-fold increases in systemic exposure and tumor uptake as compared with interferon-alpha, respectively. The in vitro antiproliferative bioactivity of the PMPC conjugate was 8.7-fold higher than that of PEGylated interferon-alpha (PEGASYS). In a murine cancer model, the PMPC conjugate completely inhibited tumor growth and cured 75% mice, whereas at the same dose, no mice treated with interferon-alpha or PEGASYS survived. We believe that this new approach to synthesize C-terminal protein conjugates of PMPC may be applicable to a large subset of protein and peptide drugs, thereby providing a general platform for the development of next-generation protein therapeutics.
Pyridine-2,6-dicarboxaldehyde-Enabled N-Terminal In Situ Growth of Polymer-Interferon Conjugates with Significantly Improved Pharmacokinetics and In Vivo Bioactivity

Jianwen Guo

DOI: https://doi.org/10.1021/acsami.0c15786

IF: 9.5

2021-01-01

ACS Applied Materials & Interfaces

Abstract:Polymer-protein conjugates are a class of biohybrids with unique properties that are highly useful in biomedicine ranging from protein therapeutics to biomedical imaging; however, it remains a considerable challenge to conjugate polymers to proteins in a site-specific, mild, and efficient way to form polymer- protein conjugates with uniform structures and properties and optimal functions. Herein we report pyridine-2,6-dicarboxaldehyde (PDA)-enabled N-terminal modification of proteins with polymerization initiators for in situ growth of poly(oligo(ethylene glycoOmethyl ether methacrylate) (POEGMA) conjugates uniquely at the N-termini of a range of natural and recombinant proteins in a mild and efficient fashion. The formed POEGMA-protein conjugates showed highly retained in vitro bioactivity as compared with free proteins. Notably, the in vitro bioactivity of a POEGMA-interferon alpha (IFN) conjugate synthesized by this new chemistry is 8.1-fold higher than that of PEGASYS that is a commercially available and Food and Drug Administration (FDA) approved PEGylated IFN. The circulation half-life of the conjugate is similar to that of PEGASYS but is 46.2 times longer than that of free IFN. Consequently, the conjugate exhibits considerably improved antiviral bioactivity over free IFN and even PEGASYS in a mouse model. These results indicate that the PDA-enabled N-terminal grafting-from method is applicable to a number of proteins whose active sites are far away from the N-terminus for the synthesis of N-terminal polymer-protein conjugates with high yield, well-retained activity, and considerably improved pharmacology for biomedical applications.
Non-covalent PEGylation of proteins mediated by site-specific in situ polymerization induced co-assembly

Fei Jiao,QInzhi Su,Xinyu Liu

DOI: https://doi.org/10.1039/d4py00260a

IF: 4.6

2024-04-26

Polymer Chemistry

Abstract:Herein we present a method tailored for non-covalent PEGylation of proteins, which is achieved by site-specific in situ polymerization induced co-assembly (SI-PICA) of proteins and polyethylene glycol (PEG). Significantly, this approach aptly preserves the bioactivity of therapeutic proteins while concurrently enhancing their pharmacokinetic properties.

polymer science
Polymerization Induced Self-Assembly of a Site-Specific Interferon Α-Block Copolymer Conjugate into Micelles with Remarkably Enhanced Pharmacology

Xinyu Liu,Mengmeng Sun,Jiawei Sun,Jin Hu,Zhuoran Wang,Jianwen Guo,Weiping Gao

DOI: https://doi.org/10.1021/jacs.8b06013

IF: 15

2018-01-01

Journal of the American Chemical Society

Abstract:Conjugating a hydrophilic and protein-resistant polymer to a protein is a widely used strategy to extend the in vivo half-life of the protein; however, the benefit of the half-life extension is usually limited by the bioactivity decrease. Herein we report a supramolecular self-assembly strategy of site-specific in situ polymerization induced self-assembly (SI-PISA) to address the dilemma. An amphiphilic block copolymer (POEGMA-PHPMA) was directly grown from the C-terminus of an important therapeutic protein interferon-α (IFN) to in situ form IFN-POEGMA-PHPMA conjugate micelles. Notably, the in vitro bioactivity of the micelles was 21.5-fold higher than that of the FDA-approved PEGylated interferon-α PEGASYS. Particularly, the in vivo half-life of the micelles (83.8 h) was 1.7- and 100-fold longer than those of PEGASYS (49.5 h) and IFN (0.8 h), respectively. In a tumor-bearing mouse model, the micelles completely suppressed tumor growth with 100% animal survival, whereas at the same dose, PEGASYS and IFN were much less effective. These findings suggest that SI-PISA is promising as a next-generation technology to remarkably enhance the pharmacological performance of therapeutic proteins with short circulation half-lives.
Stimuli-Responsive Sulfoxide Polymer–Protein Conjugates with Improved Pharmacokinetics and Tumor Delivery

Gayathri R. Ediriweera,Yixin Chang,Qiaoyun Wang,Yutong Gong,Dewan T. Akhter,Huiwen Pang,Felicity Y. Han,Chunying Chen,Andrew K. Whittaker,Changkui Fu

DOI: https://doi.org/10.1021/acs.chemmater.3c01566

IF: 10.508

2023-08-31

Chemistry of Materials

Abstract:A growing number of reports of poly(ethylene glycol) (PEG)-associated immunogenicity have prompted the development of alternative polymers for bioconjugation to assist in overcoming the poor in vivo pharmacokinetic profile of proteins. In this study, we demonstrate the development of transferrin (Tf) protein–polymer conjugates using a highly hydrophilic sulfoxide polymer (poly(2-(methylsulfinyl)ethyl acrylate) (PMSEA)) that has recently emerged as a promising class of low-fouling polymer. A cleavable thioketal linker between the protein and polymer enabled successful protein release when the conjugates were exposed to an environment rich in reactive oxygen species. Cleavage of the polymer circumvents the loss of protein activity upon chemical modification. The Tf-PMSEA conjugate was capable of significantly improving the in vivo pharmacokinetics of the protein and consequently enabled higher tumor accumulation of Tf-PMSEA in tumor-bearing mice compared to the PEGylated counterpart. This demonstrated the potential of PMSEA to be utilized in therapeutic delivery applications as a promising alternative to PEG.

materials science, multidisciplinary,chemistry, physical
Conjugation to increase treatment volume during local therapy: a case study with PEGylated camptothecin

Kraig Haverstick,Alison Fleming,W Mark Saltzman

DOI: https://doi.org/10.1021/bc700214h

Abstract:Controlled release of chemotherapy drugs from polymer implants placed directly at the tumor site is a proven method for treatment of cancers of the brain. Although this method provides high doses of drug at the tumor site, the drug does not penetrate far enough into the brain for optimum treatment in most cases. Rapid drug elimination leads to more than a 10-fold drop in concentration within 2 mm of the implant. Conjugation to water-soluble polymers, such as poly(ethylene glycol) (PEG) or dextran, has the potential to increase drug distribution in the brain. We have recently PEGylated the chemotherapy drug camptothecin and found a large increase in the extent of distribution of camptothecin in the rat brain, but most of the drug in tissue was in the less-active conjugated form. Stability of the conjugation bond, activity of the drug-polymer conjugate, solubility of the conjugate relative to the drug, and molecular weight of the polymer must all be considered in the design of a conjugate to maximize drug distribution. Therefore, to optimize the PEGylated system, we have developed a pharmacokinetic model to determine the relative importance of parameters involved in the distribution of drug-polymer conjugates after release from a polymer implant. Our modeling shows that PEGylation has the potential to increase treatment distances to more than a centimeter, which may be sufficient to prevent the recurrence of human brain tumors.
Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

Zeliang Zheng,Ryuhei Okada,Hisataka Kobayashi,Tadanobu Nagaya,Junxia Wei,Qi Zhou,Fred Lee,Tapan K Bera,Yun Gao,William Kuhlman,Chin-Hsien Tai,Ira Pastan,Tapan K. Bera

DOI: https://doi.org/10.1158/1535-7163.MCT-19-0890

2020-03-03

Molecular Cancer Therapeutics

Abstract:Recombinant immunotoxins (RIT) are chimeric proteins containing an Fv that binds to tumor cells, fused to a fragment of Pseudomonas exotoxin (PE) that kills the cell. Their efficacy is limited by their short half-life in the circulation. Chemical modification with polyethylene glycol (PEG) is a well-established method to extend the half-lives of biologics. Our goal was to engineer RITs with an increase in half-life and high cytotoxic activity. We introduced single cysteines at different locations in five anti-mesothelin RITs and employed site-specific PEGylation to conjugate them to 20-kDa PEG. Because our previous PEGylation method using β-mercaptoethanol reduction gave poor yields of PEG-modified protein, we employed a new method using tris(2-carboxyethyl)phosphine to reduce the protein and could PEGylate RITs at approximately 90% efficiency. The new proteins retained 19% to 65% of cytotoxic activity. Although all proteins are modified with the same PEG, the radius of hydration varies from 5.2 to 7.1, showing PEG location has a large effect on protein shape. The RIT with the smallest radius of hydration has the highest cytotoxic activity. The PEGylated RITs have a 10- to 30-fold increase in half-life that is related to the increase in hydrodynamic size. Biodistribution experiments indicate that the long half-life is due to delayed uptake by the kidney. Antitumor experiments show that several PEG-RITs are much more active than unmodified RIT, and the PEG location greatly affects antitumor activity. We conclude that PEGylation is a useful approach to improve the half-life and antitumor activity of RITs.

oncology
Poly(l-glutamic acid)-cisplatin nanoformulations with detachable PEGylation for prolonged circulation half-life and enhanced cell internalization

Zhongyu Jiang,Xiangru Feng,Haoyang Zou,Weiguo Xu,Xiuli Zhuang

DOI: https://doi.org/10.1016/j.bioactmat.2021.01.034

IF: 18.9

2021-09-01

Bioactive Materials

Abstract:The poly(l-glutamic acid)-cisplatin nanoformulations with detachable PEGylation are developed for cancer therapy.DePEGylation of nanoformulations triggered by tumor microenvironment exhibit enhanced tumor cell internalization.The dePEGylation strategy exhibits promising prospects for clinical application of nanomedicines.PEGylation has been widely applied to prolong the circulation times of nanomedicines via the steric shielding effect, which consequently improves the intratumoral accumulation. However, cell uptake of PEGylated nanoformulations is always blocked by the steric repulsion of PEG, which limits their therapeutic effect. To this end, we designed and prepared two kinds of poly(l-glutamic acid)-cisplatin (PLG-CDDP) nanoformulations with detachable PEG, which is responsive to specific tumor tissue microenvironments for prolonged circulation time and enhanced cell internalization. The extracellular pH (pHe)-responsive cleavage 2-propionic-3-methylmaleic anhydride (CDM)-derived amide bond and matrix metalloproteinases-2/9 (MMP-2/9)-sensitive degradable peptide PLGLAG were utilized to link PLG and PEG, yielding pHe-responsive PEG-pHe-PLG and MMP-sensitive PEG-MMP-PLG. The corresponding smart nanoformulations PEG-pHe-PLG-Pt and PEG-MMP-PLG-Pt were then prepared by the complexation of polypeptides and cisplatin (CDDP). The circulation half-lives of PEG-pHe-PLG-Pt and PEG-MMP-PLG-Pt were about 4.6 and 4.2 times higher than that of the control PLG-Pt, respectively. Upon reaching tumor tissue, PEG on the surface of nanomedicines was detached as triggered by pHe or MMP, which increased intratumoral CDDP retention, enhanced cell uptake, and improved antitumor efficacy toward a fatal high-grade serous ovarian cancer (HGSOC) mouse model, indicating the promising prospects for clinical application of detachable PEGylated nanoformulations.Download : Download high-res image (319KB)Download : Download full-size image

engineering, biomedical,materials science, biomaterials
Impact of PEGylation on biodistribution and tumor accumulation of Lipid-Mu peptide-DNA

Jing Bai,Zhengyuan Zhou,Hailing Tang,Shuxian Song,Jinliang Peng,Yuhong Xu

DOI: https://doi.org/10.3109/08982104.2012.708934

2012-10-19

Journal of Liposome Research

Abstract:For gene-based therapeutic approaches that require transfection of specific cell targets in vivo, it is important to design the delivery system to have optimized tissue distribution. Surface PEGylation of liposomes and polymer nanoparticles has been shown to lead to prolonged blood circulation and also preferential accumulation in tumor sites resulting from the enhanced permeability and retention (EPR) effect. The aim of this study was to investigate the effect of different surface PEGylation densities on resulted biodistribution profiles of Lipid-Mu peptide-DNA (LMD) nanoparticles. LMD particles containing the near infrared fluorescent lipid dye, Cy5.5-DSPE, were injected intravenously, and whole-body fluorescence images of the live animal were recorded. Analysis of these time series of images indicated that LMDs with different surface PEG(2000) densities had distinctively different biodistribution and tumor accumulation profiles. LMDs containing approximately 15-25% of surface PEG(2000) were shown to have the highest accumulation and longest residence time in tumor. LMD distribution and pharmacokinetic profiles in other organs were also observed to be different and were analyzed.

pharmacology & pharmacy,biochemistry & molecular biology
Ring-opening crosslinking PEGylation of an AIE epoxy monomer towards biocompatible fluorescent nanoparticles

Chunping Ma,Gaoyi Xie,Xiqi Zhang,Liutao Yang,Yang Li,Hongliang Liu,Ke Wang,Yen Wei

DOI: https://doi.org/10.1039/c6tb02841a

IF: 7.571

2016-01-01

Journal of Materials Chemistry B

Abstract:Here we report the ring-opening crosslinking PEGylation of an AIE epoxy monomer and a 4-arm PEG-amine to prepare a new cross-linked fluorescent polymer (PEG-EP3). When PEG-EP3 was dispersed in aqueous solution, the AIE components formed the hydrophobic cores and the PEG parts covered the surfaces, resulting in fluorescent polymeric nanoparticles (FPNs) with good dispersibility. PEG-EP3 and the resulting FPNs were characterized by gel permeation chromatography, H-1 NMR spectroscopy, FT-IR spectroscopy, X-ray photoelectron spectroscopy, dynamic light scattering, transmission electron microscopy, UV-Visible absorption and fluorescence spectra. The results confirmed the successful synthesis of PEG-EP3, which showed high water dispersibility with a size distribution of 249 +/- 1 nm, intense yellow-green fluorescence in aqueous solution with a fluorescence quantum yield of 35%, and a low critical micelle concentration (CMC) of 0.039 mg mL(-1). The cell uptake behaviour and cell imaging of the PEG-EP3 FPNs proved their high biocompatibility for biomedical applications. Owing to their excellent biocompatibility by the introduction of PEG as the main component, good colloidal stability with low CMC, and high fluorescence stability, the strategy in this work would provide a new approach to prepare novel biocompatible and robust cross-linked FPNs for biomedical applications.
Computer-Aided Site-Specific PEGylation of PET Hydrolases for Enhanced PET Degradation

Zhi Qu,Yan Sun

DOI: https://doi.org/10.1021/acsami.4c12187

IF: 9.5

2024-10-08

ACS Applied Materials & Interfaces

Abstract:The enormous accumulation of poly(ethylene terephthalate) (PET) waste has posed a serious threat to the environment and human health, and biodegradation with PET hydrolase (PETase) can be a possible solution. Herein, we propose site-specifically modifying PETase with amphiphilic polymers to improve the enzyme performance at ambient temperature. For this purpose, we devise a computer-aided strategy to prioritize the conjugation site, and polyethylene glycol (PEG) preparations of 0.55 to 10 kDa...

materials science, multidisciplinary,nanoscience & nanotechnology
Biocompatible Fluorescent Polymers from PEGylation of an Aggregation-Induced Emission Dye

Chunping Ma,Gaoyi Xie,Xiqi Zhang,Liutao Yang,Yang Li,Hongliang Liu,Ke Wang,Yen Wei

DOI: https://doi.org/10.1016/j.dyepig.2016.12.070

IF: 5.122

2017-01-01

Dyes and Pigments

Abstract:Novel aggregation-induced emission (AIE) polymers (NS1 and NS2) were prepared through reversible addition fragmentation chain transfer polymerization of poly(ethylene glycol) monomethyl ether methacylate and a new AIE monomer with a vinyl group. The NS1 and NS2 copolymers were characterized by gel permeation chromatography, H-1 NMR spectroscopy, FT-IR spectroscopy, X-ray photoelectron spectroscopy, which proved their successful syntheses. Such amphiphilic copolymers could self assemble into fluorescent polymeric nanoparticles (FPNs) in water with good dispersibility, which were spherical in shape. The prepared FPNs of NS1 had a size range of 50-150 nm, strong green fluorescence in aqueous solution With fluorescence quantum yield of 31%, and low critical micelle concentration (CMC) of 0.030 mg mL(-1). The NS2 FPNs exhibited size range of 200-300 nm, intense green fluorescence with quantum yield of 38%, and CMC of 0.037 mg mL(-1). These FPNs were demonstrated highly biocompatible for cell imaging. By virtue of excellent biocompatibility via PEG modification, good particle stability with low CMC, and AIE fluorescent polymers with high photostability, the FPNs constructed in this work showed obvious advantages. This strategy should inspire new approaches to prepare novel biocompatible AIE fluorescent polymers for biomedical application. (C) 2017 Elsevier Ltd. All rights reserved.
Site-specific in situ growth of a cyclized protein-polymer conjugate with improved stability and tumor retention.

Hu Jin,Zhao Wenguo,Gao Yan,Sun Mengmeng,Wei Yen,Deng Haiteng,Gao Weiping

DOI: https://doi.org/10.1016/j.biomaterials.2015.01.002

IF: 14

2015-01-01

Biomaterials

Abstract:A major disadvantage of therapeutic proteins is their instability to external stressors during storage, transport and use. Here, we report site-specific in situ growth of a cyclized protein-polymer conjugate with improved in vitro and in vivo stability. Green fluorescence protein (GFP) was genetically fused at its N- and C-termini with two sortase recognition sequences pentaglycine and LPETG, respectively to yield a linear GFP (l-GFP). A cyclized GFP (c-GFP) was generated from the l-GFP by sortase-catalyzed cyclization. A maleimide-functionalized atom transfer radical polymerization (ATRP) initiator was selectively attached to a free cysteine residue genetically engineered at the C-terminus of GFP to form a macroinitiator (c-GFP-Br). Subsequent in situ ATRP of oligo(ethylene glycol) methyl ether methacrylate (OEGMA) from the c-GFP-Br generated a site-specific (C-terminal) and stoichiometric (1:1) c-GFP-POEGMA conjugate with almost quantitative conversion and highly retained activity. Notably, the c-GFP-POEGMA conjugate showed 9- and 310-fold increases in thermal stability as compared to the l-GFP and its counterpart l-GFP-POEGMA, respectively. Additionally, the conjugate displayed significantly improved tumor retention relative to the l-GFP and l-GFP-POEGMA. The method developed may be applicable to a variety of therapeutic proteins to improve their in vitro and in vivo stability.
A Biocompatible Cross-Linked Fluorescent Polymer Prepared Via Ring-Opening PEGylation of 4-Arm PEG-amine, Itaconic Anhydride, and an AIE Monomer

Chunping Ma,Xiqi Zhang,Ke Wang,Xiaoyong Zhang,Yahong Zhou,Hongliang Liu,Yen Wei

DOI: https://doi.org/10.1039/c5py00111k

IF: 4.6

2015-01-01

Polymer Chemistry

Abstract:A biocompatible cross-linked fluorescent polymer is prepared via ring-opening PEGylation of an AIE monomer, itaconic anhydride, and 4-arm PEG-amine.
Surface tailoring of poly(ethylene terephthalate) via ligand-tethered comb-like PEG to enhance endothelialization

Xiaolin Li,Jian Ji,Ming Pu,Xiaoli Wang,Jiacong Shen

DOI: https://doi.org/10.1007/s10856-006-0110-1

2007-01-01

Abstract:The comb-like PEG (CPEG) end-tethered with l -lysine was explored to surface modification of PET to enhance endothelialization. The hydroxyl end groups of CPEG were oxygenated into aldehyde groups. The CPEG-CHO was grafted onto the aminolysized PET. The l -lysine was then end-tethered onto surface via the residual aldehyde groups. The surface modification was confirmed by ATR-FTIR, contact angle and XPS measurements. The endothelial cell adhesion, proliferation and viability results indicated that the PET-CPEG resisted cell adhesion and growth, where as PET-CPEG-lysine promoted cell adhesion and growth. The MTT assay and total cell protein tests indicated that the endothelial cells on PET-CPEG-lysine had high viability. Cell spread uniformly and covered completely on the PET-CPEG-lysine. The CPEG end tethered with l -lysine could regulate cell adhesion and growth and enhance surface endotheliazation.
An acid-labile block copolymer of PDMAEMA and PEG as potential carrier for intelligent gene delivery systems.

Song Lin,Fusheng Du,Yang Wang,Shouping Ji,Dehai Liang,Lei Yu,Zichen Li

DOI: https://doi.org/10.1021/bm7008747

2008-01-01

Biomacromolecules

Abstract:Intelligent gene delivery systems based on physiologically triggered reversible shielding technology have evinced enormous interest due to their potential in vivo applications. In the present work, an acid-labile block copolymer consisting of poly(ethylene glycol) and poly(2-(dimethylamino)ethyl methacrylate) segments connected through a cyclic ortho ester linkage (PEG-a-PDMAEMA) was synthesized by atom transfer radical polymerization of DMAEMA using a PEG macroinitiator with an acid-cleavable end group. PEG-a-PDMAEMA condensed with plasmid DNA formed polyplex nanoparticles with an acid-triggered reversible PEG shield. The pH-dependent shielding/deshielding effect of PEG chains on the polyplex particles were evaluated by potential and size measurements. At pH 7.4, polyplexes generated from PEG-a-PDMAEMA exhibited smaller particle size, lower surface charge, reduced interaction with erythrocytes, and less cytotoxicity compared to PDMAEMA-derived polyplexes. At pH 5.0, zeta potential of polyplexes formed from PEG-a-PDMAEMA increased, leveled up after 2 h of incubation and gradual aggregation occurred in the presence of bovine serum albumin (BSA). In contrast, the stably shielded polyplexes formed by DNA and an acid-stable block copolymer, PEG-b-PDMAEMA, did not change in size and zeta potential in 6 h. In vitro transfection efficiency of the acid-labile copolymer greatly increased after 6 h incubation at pH 5.0, approaching the same level of PDMAEMA, whereas there was only slight increase in efficiency for the stable copolymer, PEG-b-PDMAEMA.

In situ Polymerization of a PEG Monomer from the C-Terminus of an Intein Fusion Protein Significantly Improves Pharmacokinetics and Tumor Accumulation

In Situ Growth Of A Peg-Like Polymer From The C Terminus Of An Intein Fusion Protein Improves Pharmacokinetics And Tumor Accumulation

A Novel Zwitterionic Copolymer with A Short Poly(Methyl Acrylic Acid) Block for Improving Both Conjugation and Separation Efficiency of A Protein Without Losing Its Bioactivity

A facile entrapment approach to construct PEGylated polyplexes for improving stability in physiological condition.

In Situ Growth Of A Stoichiometric Peg-Like Conjugate At A Protein'S N-Terminus With Significantly Improved Pharmacokinetics

Site-specific in Situ Growth of an Interferon-Polymer Conjugate That Outperforms PEGASYS in Cancer Therapy.

Pyridine-2,6-dicarboxaldehyde-Enabled N-Terminal In Situ Growth of Polymer-Interferon Conjugates with Significantly Improved Pharmacokinetics and In Vivo Bioactivity

Non-covalent PEGylation of proteins mediated by site-specific in situ polymerization induced co-assembly

Polymerization Induced Self-Assembly of a Site-Specific Interferon Α-Block Copolymer Conjugate into Micelles with Remarkably Enhanced Pharmacology

Stimuli-Responsive Sulfoxide Polymer–Protein Conjugates with Improved Pharmacokinetics and Tumor Delivery

Conjugation to increase treatment volume during local therapy: a case study with PEGylated camptothecin

Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

Poly(l-glutamic acid)-cisplatin nanoformulations with detachable PEGylation for prolonged circulation half-life and enhanced cell internalization

Impact of PEGylation on biodistribution and tumor accumulation of Lipid-Mu peptide-DNA

Ring-opening crosslinking PEGylation of an AIE epoxy monomer towards biocompatible fluorescent nanoparticles

Computer-Aided Site-Specific PEGylation of PET Hydrolases for Enhanced PET Degradation

Biocompatible Fluorescent Polymers from PEGylation of an Aggregation-Induced Emission Dye

Site-specific in situ growth of a cyclized protein-polymer conjugate with improved stability and tumor retention.

A Biocompatible Cross-Linked Fluorescent Polymer Prepared Via Ring-Opening PEGylation of 4-Arm PEG-amine, Itaconic Anhydride, and an AIE Monomer

Surface tailoring of poly(ethylene terephthalate) via ligand-tethered comb-like PEG to enhance endothelialization

An acid-labile block copolymer of PDMAEMA and PEG as potential carrier for intelligent gene delivery systems.